Examining blood transfusion methods for children with severe bleeding
Official title: Massive Transfusion in Children: a Platform RCT of Whole Blood Compared to Component Therapy and Tranexamic Acid to Placebo in Life-threatening Traumatic Bleeding
Run by University of Pittsburgh · NCT06070350 · Data updated 2026-11-12
This study is testing whether using a specific type of blood and a medication can help children with severe bleeding from injuries survive better than standard treatments.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | Any age to 17 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 23 sites (Tucson, Arizona and 22 other locations) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | June 1, 2028 |
| Study ends | October 1, 2028 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT06070350 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children under 18 years old with confirmed or suspected active life-threatening traumatic bleeding.
✕Probably not a fit
Patients with devastating traumatic brain injuries not expected to survive or those who have not received blood products may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The MATIC-2 trial is a multicenter, phase III clinical trial focused on children under 18 years old who are experiencing hemorrhagic shock due to traumatic injuries. It aims to compare the effectiveness of Low Titer Group O Whole Blood (LTOWB) against component therapy (CT) and Tranexamic Acid (TXA) against a placebo in reducing 24-hour all-cause mortality. Participants will be randomized to receive either LTOWB or CT, and TXA or placebo, with the study also assessing safety outcomes related to these interventions. The trial employs a Bayesian adaptive design to enhance its efficiency and responsiveness.
Why it matters
Potential benefit: If successful, this study could significantly reduce mortality rates in children suffering from traumatic life-threatening hemorrhage.
How similar studies have gone: Other studies have shown promise in using whole blood for transfusions, but this specific approach is novel and untested in this pediatric population.
Who can join: the full rules
Show full inclusion / exclusion criteria
General Inclusion Criteria: 1. Children, defined as less than estimated18 years of age with traumatic injury 2. MTP activation for confirmed or suspected active life-threatening traumatic bleeding AND Confirmed or suspected active life-threatening traumatic bleeding with at least 2 of 3 of the following criteria: 1. Hypotension for age (\< 5% tile) 2. Tachycardia for age (\>95th % tile) 3. Traumatic injury with exam findings consistent with severe bleeding (e.g., penetrating injury, hemothorax, distended abdomen with bruising, amputation of limb). General Exclusion Criteria: 1. Patient with devastating traumatic brain injury not expected to survive due to magnitude of injury (example: Transhemispheric gunshot wound with signs of herniation, GCS score of 3 with fixed and dilated pupils) 2. MTP activated but no blood products given 3. Patients who required an ED thoracotomy or received more than 5 consecutive minutes of cardiopulmonary resuscitation (prior to receiving randomized blood products) 4. Patients who are known or suspected to be pregnant on clinical examination 5. Known prisoners as defined in protocol 6. Known ward of the state 7. Isolated hanging, drowning or burns 8. Previous enrollment in MATIC-2 9. Prior study opt-out with bracelet Exclusion Criteria for the TXA/Placebo Domain 1. Prehospital or pre-enrollment use of TXA 2. Greater than 3 hours since time of injury 3. History of seizure after the injury event 4. Known allergy or hypersensitivity reaction to TXA
Where it's running
-
University of Arizona
Tucson, Arizona, United States Recruiting -
Arkansas Children's Hospital
Little Rock, Arkansas, United States Recruiting -
University of California Davis
Sacramento, California, United States Recruiting -
Children's National Hospital
Washington D.C., District of Columbia, United States Recruiting -
Emory University-Arthur M. Blank Hospital
Atlanta, Georgia, United States Recruiting -
University of Mississippi Medical Center
Jackson, Mississippi, United States Recruiting
Show 17 more locations
-
Washington University of St. Louis
St Louis, Missouri, United States Recruiting -
University of New Mexico
Albuquerque, New Mexico, United States Recruiting -
Wake Forest University Health Sciences
Wake Forest, North Carolina, United States Recruiting -
Nationwide Children's Hospital
Columbus, Ohio, United States Recruiting -
Oregon Health and Science University
Portland, Oregon, United States Recruiting -
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, United States Recruiting -
LeBonheur Children's Hospital
Memphis, Tennessee, United States Recruiting -
Baylor College of Medicine
Houston, Texas, United States Recruiting -
Children's Memorial Hermann Hospital
Houston, Texas, United States Recruiting -
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States Recruiting -
Primary Children's Hospital
Salt Lake City, Utah, United States Recruiting -
University of Washington Harborview
Seattle, Washington, United States Recruiting -
Medical College of Wisconsin
Milwaukee, Wisconsin, United States Recruiting -
Emory University-Scottish Rite Hospital
Atlanta, Georgia, United States Terminated -
Tulane School of Medicine
New Orleans, Louisiana, United States Withdrawn -
Vanderbilt University Medical Center
Nashville, Tennessee, United States Not yet recruiting -
The University of Texas Southwestern Medical Center
Dallas, Texas, United States Terminated
Study contacts
- Principal investigator: Philip C Spinella, MD — Univesrity of Pittsburgh
- Study coordinator: Thomas Byers
- Email: tdb33@pitt.edu
- Phone: 412-383-2340
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Geriatric Trauma Care Program for Older Adults Living Alone
This study tests a digital support program to help older adults with limb injuries who live alone see if it improves their recovery and daily living after injury.
-
Mortality in the ICU after trauma in Colombia
This study tests what factors are linked to death among trauma patients admitted to the ICU and compares them with other ICU admissions in Colombian hospitals.
-
Regional anesthesia techniques for pain control after pelvic and acetabular fracture surgery
This study will try regional anesthesia techniques to see if they lower pain and opioid use after pelvic or acetabular fracture surgery.
-
Using platelet-lymphocyte and platelet-neutrophil ratios to detect early trauma-related coagulopathy
This research will test if blood-count ratios (PLR and PNR) taken within six hours of injury can help detect early trauma-induced coagulopathy in patients who come to the emergency department.
-
Electrical bioimpedance imaging for high-energy limb fractures
This will test whether a portable electrical impedance tomography (EIT) device can image tissue changes in adults with high-energy closed limb fractures.
-
Therapy dog visits for hospitalized trauma patients
This project will test whether short visits from therapy dogs reduce pain and anxiety in adults hospitalized with traumatic injuries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.